ATROPINE ENHANCES NEUROMUSCULAR TRANSMISSION IN HUMANS

Neuromuscular transmission
DOI: 10.1111/j.1472-8206.1987.tb00545.x Publication Date: 2009-08-26T18:14:08Z
ABSTRACT
Summary— The effect of atropine (1–10 μ‐kg‐ 1 ) on neuromuscular transmission in humans was studied by analysing its effects the amplitude indirectly‐elicited twitch (0.2 Hz) and tetanic (50 100 Hz for s duration) contractions. Six patients, free from any disorders, undergoing orthopaedic surgery, were included present study. patients received either no premedication or oral benzodiazepine, temazepam, 30 mg 1–2 h pre‐operatively. Anaesthesia induced with propofol (1–2 mg‐kg‐ , i.v., over 20 s). breathed less than 30% oxygen nitrous oxide, halothane (1%) enflurane (1–2%). Incremental doses fentanyl (50–100 μ) given to provide additional analgesia. ulnar nerve stimulated, supramaximally, at wrist, control mechanical responses adductor pollicis muscle, stimulation 50 duration, recorded. Theses repeated 2, 5 10 min intervals, after injection ). At same time, heart rate blood pressures (systolic diastolic) results showed that enhanced contractions, elicited 27 ± 1.2% atropine, 220 13 g tension), 43 7% (100 333 26 tension) intervals (mean S.E., n = 6). also increased, 24 2.5% (heart 110±3.5 beats/min), 16±1.0% 138±2.2 mm Hg), 13±1.1% (diastolic 76±1.5 this precluded use higher ( e.g. 1.2 mg, i.e. our mechanism action junction, are discussed reference animal work, which has been shown enhance and/or transmitter (ACh) release, possibly acting muscarinic presynaptic inhibitory receptors, involved feedback release.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (14)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....